Dr. Ramya Ramesh Malchira, MD

Dr. Malchira practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Malchira's NPI, 1275810921, was assigned on November 9, 2011. Dr. Malchira graduated from Kempegowda Institute of Medical Science in 2004. Dr. Malchira's California license number on file is A118929.

Dr. Malchira's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Malchira's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Malchira is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Malchira to 2 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malchira practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Malchira's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Malchira is board certified in internal medicine by the American Board of Internal Medicine. Dr. Malchira has a license on file in California.

Dmand AI lists acid reflux, acute kidney failure, acute mini-stroke (TIA), aneurysm, anxiety, atrial fibrillation and flutter, bladder disease and chronic diabetes among the conditions Dr. Malchira treats.

CMS data shows 2,718 Medicare services from Dr. Malchira across 18 procedure codes in 2024, for 759 Medicare patients. Medicare paid $200,004 for them.

CMS counts 759 Medicare patients who saw Dr. Malchira in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malchira's median patient age at 70, with 58% women.

In 2024, Dr. Malchira wrote 3,475 Medicare Part D claims for 422 patients. 91% of them were for generic drugs. CMS names the drug for 3,008 of them, across 81 drugs with 11 or more claims each, at $211,981 in total drug cost. In 2023, CMS named 2,941 claims across 77 drugs.

Dr. Malchira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malchira as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Malchira from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $146.

Dr. Malchira graduated from Kempegowda Institute of Medical Science in 2004.

Dr. Malchira is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.